Korea

SK TELECOM CO. LTD. FILES ITS ANNUAL REPORT ON FORM 20-F

SEOUL, South Korea, April 27, 2023 /PRNewswire/ -- On April 27, 2023, SK Telecom Co., Ltd. filed its Annual Report on Form 20-F for the year ended December 31, 2022 with the U.S. Securities and Exchange Commission. The 2022 Annual Report on Form 20-F can be viewed on www.sktelecom.com

2023-04-27 19:40 2669

KB FINANCIAL GROUP INC. FILES ITS ANNUAL REPORT ON FORM 20-F

SEOUL, South Korea, April 26, 2023 /PRNewswire/ -- On April 26, 2023, KB Financial Group Inc. filed its Annual Report on Form 20-F for the year ended December 31, 2022 with the U.S. Securities and Exchange Commission.  The 2022 Annual Report on Form 20-F can be downloaded fromwww.kbfg.com

2023-04-26 18:56 2169

J INTS BIO, AACR 2023 - Presentation of preclinical study results of 'JIN-A04', an oral target therapy for HER2 exon insertion mutation NSCLC

SEOUL, South Korea, April 25, 2023 /PRNewswire/ -- J INTS BIO announced the poster presentation of its novel, orally administered TKI 'JIN-A04' targeting NSCLC with HER2 exon 20 insertion mutation at the annual meeting of the American Association of Cancer Research 2023, which was held inOrlando,...

2023-04-26 09:53 1660

LG Energy Solution Records Fifth Consecutive Quarterly Revenue Growth

* LGES posts the quarterly revenue of KRW 8.7 trillion and operating profit of KRW 633 billion in the first quarter of 2023 * LGES batteries, manufactured and sold this year, fulfill the IRA requirement for battery components and critical minerals, meeting customers' needs for EV tax credit el...

2023-04-26 09:30 2007

SK hynix Reports First Quarter 2023 Financial Results

* Revenues at 5.088 trillion won, operating loss at 3.402 trillion won, net loss at2.586 trillion won * Operating loss continues due to weak demand and price fall of memory chips; Revenues expected to improve in Q2 * "Company to lead premium memory market with flagship products including DD...

2023-04-26 07:29 2516

Criminal IP: A Cybersecurity OSINT Search Engine at RSA Conference Right After Its Official Service Release

TORRANCE, Calif., April 25, 2023 /PRNewswire/ -- Criminal IP, a cutting-edge OSINT-based search engine, provided by AI Spera Inc., is attending the RSA Conference  from April 24 to 27 in San Francisco . Visit booth S-634 to experience a comprehensive solution to imp...

2023-04-25 23:00 1903

BIORCHESTRA Scientific Founder, Chairman, and Chief Executive Officer Joins the Republic of Korea (ROK) Official State Visit to the United States

* The Official State visit by the President of the Republic of Korea marks the 70th anniversary of the U.S.-ROK alliance, which is advancing peace, stability, and prosperity for the two countries, for theAsia-Pacific region, and globally * President Yoon Suk Yeol and First Lady Kim Keon Hee o...

2023-04-25 20:00 1506

Mediso launches next generation MRI spectrometer spinScan®

BUDAPEST, Hungary, April 25, 2023 /PRNewswire/ -- Mediso released their next generation MRI spectrometer spinScan® the successor to the previously used console in the nanoScan® MRI product line. The new spectrometer was optimized for MRI applications delivering an ultra-low-...

2023-04-25 16:00 1919

AITRICS to Participate in HIMSS USA 2023

* Introducing an AI Solution for predicting patient deterioration, 'VitalCare' * Second HIMSS USA Participation...Finding potential customers and establishing a foothold in the US market SEOUL, South Korea, April 24, 2023 /PRNewswire/ -- AITRICS (CEO Kwang joon Kim, Jin-gyu Yoo), a company spe...

2023-04-24 21:00 1773

CJ FNT Launches Functional Nutrition Brand, "ActiveNrich™"

*  A new Specialty brand focusing on nutritional solutions for food and supplement categories catering to the customer needs *  ActiveNrich™ is making its global debut with natural antioxidant solution in Q2 SEOUL, South Korea, April 24, 2023 /PRNewswire/ -- CJ Food & Nutrition Tech (CJ FNT) ...

2023-04-24 21:00 1885

BIORCHESTRA Announces Significant Progress in Studies of BMD-001 Drug Program

* Encouraging non-human primate (NHP) findings support the progression of IV-formulatedBMD-001 ahead of formal clinical studies for Alzheimer's disease, Amyotrophic Lateral Sclerosis, and Parkinson's disease * Further validation of Brain Targeting RNAi Nanomedicine (BTRiNTM), including target...

2023-04-24 20:00 1399

Hyundai Mobis' e-Corner System Featuring Crab Walking and Zero Turn Becomes the First in the World to Drive on Public Roads

* Parallel park, forward park, or escape from a dead end with four wheels that rotate up to 90° altogether or separately * A key solution for autonomous driving and PBVs that has secured reliability through the successful demonstration on public roads * In line with the bespoke mobility tren...

2023-04-24 20:00 3501

Samsung Biologics Reports First Quarter 2023 Financial Results

* Recorded Q1'23 consolidated revenue of KRW 720.9 billion. * Recorded Q1'23 consolidated operating profit of KRW 191.7 billion. * Expected to maintain a strong growth trajectory with the full utilization of existing and newly expanded capacities. INCHEON, South Korea, April 24, 2023 /PRNews...

2023-04-24 14:51 2277

Bridge Biotherapeutics Receives FDA Authorization to Proceed with the First-in-Human Study of BBT-207, a 4th generation EGFR TKI

* The company has been notified by the FDA that the Phase 1/2 clinical trial may proceed * The latest preclinical data explored the antitumor efficacy and the intracranial activity of BBT-207 SEONGNAM, South Korea and CAMBRIDGE, Mass., April 23, 2023 /PRNewswire/ -- Bridge Biotherapeutics (KQ...

2023-04-24 10:00 1649

2023 Cheongju International Craft Competition submission until May 7th, total prize money is 143 million won

CHEONGJU, South Korea, April 21, 2023 /PRNewswire/ -- The Cheongju Craft Biennale Organizing Committee (Chairman LEE, Beom-Seog, Mayor of Cheongju City) accepts online submissions for the '2023 Cheongju International Craft Competition' on the official website (http://ccbcompetition.com

2023-04-21 20:51 2694

Shinhan Financial Group files its FY2022 Form 20-F to the SEC

SEOUL, South Korea, April 20, 2023 /PRNewswire/ -- Shinhan Financial Group (NYSE: SHG) (KRX:055550) filed its Annual Report on Form 20-F for the year ended December 31, 2022 with the U.S. Securities and Exchange Commission (SEC) on April 20, 2023. The report is available at Shinhan Financial Group...

2023-04-21 08:00 3073

Samyang Holdings Enters Partnership with LG Chem for the Development of Innovative Cancer Therapeutics

* Implementation of Samyang Holdings' drug delivery technology for the development of mRNA-based cancer therapeutics SEOUL, South Korea, April 20, 2023 /PRNewswire/ -- Samyang Holdings and LG Chem have announced their recent execution of strategic partnership agreement onThursday, April 20th, f...

2023-04-20 20:30 1776

SK hynix Develops Industry's First 12-Layer HBM3, Provides Samples To Customers

* Develops HBM3 product with industry's largest 24GB memory capacity; customers' performance evaluation of samples underway * Features high-capacity and high-performance through stacking of 12 DRAM chips * Plans to complete preparation for mass production by first half of 2023, aimed at sol...

2023-04-20 08:00 1816

Hyundai Mobis joins Auto Shanghai 2023, aiming to win orders USD 1B in China

* Hyundai Mobis joins Auto Shanghai 2023 on the 18th-27th, and exhibits 24 latest innovations including IVI and electrification products. * Invites over 200 CEOs and the C-suite from more than 80 global automakes such as BYD, BMW and Stellantis. * Unveils e-CCPM, the future electrification p...

2023-04-19 14:00 2722

Bridge Biotherapeutics Releases Updated Preclinical Data for BBT-207 at the AACR Annual Meeting

* New preclinical data validate anti-tumor efficacy and intracranial activity of the drug candidate * Bridge submitted an IND application to the U.S. Food and Drug Administration in March, and expects to initiate the first-in-human study of BBT-207 this year SEONGNAM, South Korea and CAMBRIDG...

2023-04-19 07:00 1792
1 ... 42434445464748 ... 111

Week's Top Stories